Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Kusaba

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Oncology Letters|September 12, 2012
Irinotecan-based combination chemotherapy for metastatic small intestinal adenocarcinomaYoshihiro Shibata, Eishi Baba, Hiroshi Ariyama, et al.
Journal of Cardiology Cases|November 14, 2019
Atrial fibrillation observed in a patient with esophageal cancer treated with fluorouracilShohei Moriyama, Taku Yokoyama, Kei Irie, et al.
Biochemical and Biophysical Research Communications|August 24, 2020
RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cellsNobuhiro Tsuruta, Kenji Tsuchihashi, Hirofumi Ohmura, et al.
Experimental Cell Research|June 9, 2012
Human Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cellsKeita Uchino, Gen Hirano, Minako Hirahashi, et al.
Case Reports in Medicine|September 1, 2009
Effective monotherapy with amrubicin for a refractory extrapulmonary small-cell carcinoma of the liverTaichi Isobe, Shunichi Yanai, Hitoshi Kusaba, et al.
Anti-Cancer Drugs|March 22, 2006
In-vitro differential metabolism and activity of 5-fluorouracil between short-term, high-dose and long-term, low-dose treatments in human squamous carcinoma cellsBaoli Qin, Risa Tanaka, Hiroshi Ariyama, et al.
Anti-Cancer Drugs|March 22, 2006
In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell linesBaoli Qin, Risa Tanaka, Yoshihiro Shibata, et al.
Cancer Chemotherapy and Pharmacology|December 12, 2012
Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancerHitoshi Kusaba, Taito Esaki, Junji Kishimoto, et al.
BMC Research Notes|June 21, 2014
Favorable control of rapidly progressive retroperitoneal pleomorphic leiomyosarcoma with multimodality therapy: a case reportKosuke Sagara, Kotoe Takayoshi, Eiji Kusumoto, et al.
Cancer Chemotherapy and Pharmacology|December 1, 2010
Phase II study of sequential treatment with S-1 and cisplatin for metastatic gastric cancerEishi Baba, Taito Esaki, Hiroshi Ariyama, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Oncology Letters|September 12, 2012
Irinotecan-based combination chemotherapy for metastatic small intestinal adenocarcinomaYoshihiro Shibata, Eishi Baba, Hiroshi Ariyama, et al.
Journal of Cardiology Cases|November 14, 2019
Atrial fibrillation observed in a patient with esophageal cancer treated with fluorouracilShohei Moriyama, Taku Yokoyama, Kei Irie, et al.
Biochemical and Biophysical Research Communications|August 24, 2020
RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cellsNobuhiro Tsuruta, Kenji Tsuchihashi, Hirofumi Ohmura, et al.
Experimental Cell Research|June 9, 2012
Human Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cellsKeita Uchino, Gen Hirano, Minako Hirahashi, et al.
Case Reports in Medicine|September 1, 2009
Effective monotherapy with amrubicin for a refractory extrapulmonary small-cell carcinoma of the liverTaichi Isobe, Shunichi Yanai, Hitoshi Kusaba, et al.
Anti-Cancer Drugs|March 22, 2006
In-vitro differential metabolism and activity of 5-fluorouracil between short-term, high-dose and long-term, low-dose treatments in human squamous carcinoma cellsBaoli Qin, Risa Tanaka, Hiroshi Ariyama, et al.
Anti-Cancer Drugs|March 22, 2006
In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell linesBaoli Qin, Risa Tanaka, Yoshihiro Shibata, et al.
Cancer Chemotherapy and Pharmacology|December 12, 2012
Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancerHitoshi Kusaba, Taito Esaki, Junji Kishimoto, et al.
BMC Research Notes|June 21, 2014
Favorable control of rapidly progressive retroperitoneal pleomorphic leiomyosarcoma with multimodality therapy: a case reportKosuke Sagara, Kotoe Takayoshi, Eiji Kusumoto, et al.
Cancer Chemotherapy and Pharmacology|December 1, 2010
Phase II study of sequential treatment with S-1 and cisplatin for metastatic gastric cancerEishi Baba, Taito Esaki, Hiroshi Ariyama, et al.
Pageof 11